Authors:
Kim, D
Wang, LP
Caldwell, CG
Chen, P
Finke, PE
Oates, B
MacCoss, M
Mills, SG
Malkowitz, L
Gould, SL
DeMartino, JA
Springer, MS
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Carver, G
Carella, A
Holmes, K
Lineberger, J
Schleif, WA
Emini, EA
Citation: D. Kim et al., Discovery of human CCR5 antagonists containing hydantoins for the treatment of HIV-1 infection, BIOORG MED, 11(24), 2001, pp. 3099-3102
Authors:
Kim, D
Wang, LP
Caldwell, CG
Chen, P
Finke, PE
Oates, B
MacCoss, M
Mills, SG
Malkowitz, L
Gould, SL
DeMartino, JA
Springer, MS
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Carver, G
Carella, A
Holmes, K
Lineberger, J
Schleif, WA
Emini, EA
Citation: D. Kim et al., Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection, BIOORG MED, 11(24), 2001, pp. 3103-3106
Authors:
Willoughby, CA
Berk, SC
Rosauer, KG
Degrado, S
Chapman, KT
Gould, SL
Springer, MS
Malkowitz, L
Schleif, WA
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Holmes, K
Lineberger, J
Carella, A
Carver, G
Emini, EA
Citation: Ca. Willoughby et al., Combinatorial synthesis of CCR5 antagonists, BIOORG MED, 11(24), 2001, pp. 3137-3141
Authors:
Hale, JJ
Budhu, RJ
Holson, EB
Finke, PE
Oates, B
Mills, SG
MacCoss, M
Gould, SL
DeMartino, JA
Springer, MS
Siciliano, S
Malkowitz, L
Schleif, WA
Hazuda, D
Miller, M
Kessler, J
Danzeisen, R
Holmes, K
Lineberger, J
Carella, A
Carver, G
Emini, E
Citation: Jj. Hale et al., 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity, BIOORG MED, 11(20), 2001, pp. 2741-2745
Authors:
Dorn, CP
Finke, PE
Oates, B
Budhu, RJ
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
Citation: Cp. Dorn et al., Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 1: Discovery and initial structure-activity relationships for 1-amino-2-phenyl-4-(piperidin-1-yl)butanes, BIOORG MED, 11(2), 2001, pp. 259-264
Authors:
Finke, PE
Meurer, LC
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Daugherty, BL
Gould, SL
DeMartino, JA
Siciliano, SJ
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
Citation: Pe. Finke et al., Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: Structure-activity relationships for substituted 2-aryl-1-[N-(methyl)-N-(phenylsulfonyl) amino]-4-(piperidin-1-yl)butanes, BIOORG MED, 11(2), 2001, pp. 265-270
Authors:
Finke, PE
Meurer, LC
Oates, B
Shah, SK
Loebach, JL
Mills, SG
MacCoss, M
Castonguay, L
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Citation: Pe. Finke et al., Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)4-[4-(substituted)piperidin-1yl]butanes, BIOORG MED, 11(18), 2001, pp. 2469-2473
Authors:
Finke, PE
Oates, B
Mills, SG
MacCoss, M
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Carella, A
Carver, G
Holmes, K
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Schleif, WA
Emini, EA
Citation: Pe. Finke et al., Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: Synthesis and structure-activity relationships for 1-[N(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N- (benzyloxycarbonyl)amino)piperidin-1-yl)butanes, BIOORG MED, 11(18), 2001, pp. 2475-2479
Authors:
Hale, JJ
Budhu, RJ
Mills, SG
MacCoss, M
Malkowitz, L
Siciliano, S
Gould, SL
DeMartino, JA
Springer, MS
Citation: Jj. Hale et al., 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 1: Discovery of the pyrrolidine scaffold and determination of its stereochemical requirements, BIOORG MED, 11(11), 2001, pp. 1437-1440
Authors:
Singer, II
Scott, S
Kawka, DW
Chin, J
Daugherty, BL
DeMartino, JA
DiSalvo, J
Gould, SL
Lineberger, JE
Malkowitz, L
Miller, MD
Mitnaul, L
Siciliano, SJ
Staruch, MJ
Williams, HR
Zweerink, HJ
Springer, MS
Citation: Ii. Singer et al., CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells, J VIROLOGY, 75(8), 2001, pp. 3779-3790
Citation: Ma. Cascieri et Ms. Springer, The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention, CURR OP C B, 4(4), 2000, pp. 420-427
Authors:
Di Salvo, J
Koch, GE
Johnson, KE
Blake, AD
Daugherty, BL
DeMartino, JA
Sirotina-Meisher, A
Liu, Y
Springer, MS
Cascieri, MA
Sullivan, KA
Citation: J. Di Salvo et al., The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both G(alpha i)-coupled and uncoupled states, EUR J PHARM, 409(2), 2000, pp. 143-154
Authors:
Springer, MS
Amrine, HM
Burk, A
Stanhope, MJ
Citation: Ms. Springer et al., Additional support for Afrotheria and Paenungulata, the performance of mitochondrial versus nuclear genes, and the impact of data partitions with heterogeneous base composition, SYST BIOL, 48(1), 1999, pp. 65-75
Authors:
Siciliano, SJ
Kuhmann, SE
Weng, YM
Madani, N
Springer, MS
Lineberger, JE
Danzeisen, R
Miller, MD
Kavanaugh, MP
DeMartino, JA
Kabat, D
Citation: Sj. Siciliano et al., A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1, J BIOL CHEM, 274(4), 1999, pp. 1905-1913
Authors:
Koo, GC
Blake, JT
Shah, K
Staruch, MJ
Dumont, F
Wunderler, D
Sanchez, M
McManus, OB
Sirotina-Meisher, A
Fischer, P
Boltz, RC
Goetz, MA
Baker, R
Bao, JM
Kayser, F
Rupprecht, KM
Parsons, WH
Tong, XC
Ita, IE
Pivnichny, J
Vincent, S
Cunningham, P
Hora, D
Feeney, W
Kaczorowski, G
Springer, MS
Citation: Gc. Koo et al., Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels, CELL IMMUN, 197(2), 1999, pp. 99-107
Authors:
Springer, MS
Westerman, M
Kavanagh, JR
Burk, A
Woodburne, MO
Kao, DJ
Krajewski, C
Citation: Ms. Springer et al., The origin of the Australasian marsupial fauna and the phylogenetic affinities of the enigmatic monito del monte and marsupial mole, P ROY SOC B, 265(1413), 1998, pp. 2381-2386